You're using a free limited version of DrugPatentWatch: ➤ Start for $299 All access. No Commitment.

Last Updated: December 16, 2025

Profile for Argentina Patent: 045378


✉ Email this page to a colleague

« Back to Dashboard


US Patent Family Members and Approved Drugs for Argentina Patent: 045378

The international patent data are derived from patent families, based on US drug-patent linkages. Full freedom-to-operate should be independently confirmed.
US Patent Number US Expiration Date US Applicant US Tradename Generic Name
7,452,895 Nov 16, 2025 Seagen TUKYSA tucatinib
>US Patent Number >US Expiration Date >US Applicant >US Tradename >Generic Name

Analysis of the Scope, Claims, and Patent Landscape for Argentina Patent AR045378

Last updated: July 30, 2025


Introduction

Patent AR045378 pertains to a specific pharmaceutical invention registered in Argentina. This patent's scope, claims, and landscape considerations are crucial for stakeholders involved in the development, commercialization, or legal navigation of related drug products. This analysis offers an in-depth understanding of these patents' structural and strategic contexts within Argentina's intellectual property framework.


Patent Overview and Technical Focus

AR045378 was granted in Argentina, likely covering a medicinal compound, formulation, or a method of use, typical of pharmaceutical patents. Given details from patent records, this patent appears to specify a novel composition, manufacturing process, or therapeutic application designed to address specific clinical needs. It may target a novel active ingredient, combination, or delivery system—details that significantly influence scope and enforcement.


Scope and Claims Analysis

1. Nature and Breadth of Claims

Patent claims define the scope of legal protection. An analysis reveals:

  • Independent Claims: Usually describe the core invention, such as a new compound, formulation, or method. The language’s scope determines enforceability and potential for infringement.

  • Dependent Claims: Add specificity, elaborating on particular embodiments or features.

In AR045378, claims likely cover:

  • The chemical composition of a compound or combination of compounds with pharmaceutical activity.
  • The method of manufacturing or preparation steps.
  • The therapeutic use or indication, providing method claims targeting treatment areas.
  • Formulation specifics, such as dosage forms, excipients, or delivery mechanisms.

The breadth of claims influences patent strength—narrow claims risk easy design-around, while broad claims risk invalidation for lack of novelty or inventive step.

2. Claim Language and Patent Scope Implications

The language likely employs terms like "comprising," indicating open-ended coverage, or "consisting of," for narrow scope. The presence of functional language related to therapeutic efficacy broadens scope but risks indefiniteness. The detailed description and examples further refine the proceeding claims' interpretive boundaries.


Legal and Technical Validity

1. Novelty and Inventive Step

Patent AR045378's validity hinges on:

  • Novelty: The claimed invention must differ from existing publications, prior patents, or known prior art in Argentina and more broadly.

  • Inventive step: The invention must not be obvious to a person skilled in the art at the filing date.

Given Argentina's examination standards aligned with the Patent Law (Law No. 24,481), the patent would have been assessed for these criteria, considering local and international prior art.

2. Patent Term and Maintenance

Argentina grants patents for 20 years from the filing date, subject to maintenance fees. Timely renewal ensures the patent's enforceability and commercial value.


Patent Landscape and Competitive Environment

1. Domestic and International Patent Filings

The analysis of patent landscapes shows:

  • Patent Family Members: If this patent is part of an international family, similar patents may exist in jurisdictions like the US, EP, or PCT applications, indicating broader market and legal strategy.

  • Prior Art and Competitors: Companies operating in Argentina's pharmaceutical sector—local and multinational—may have filed related patents or are actively developing similar inventions.

2. Landscape Mapping and Freedom-to-Operate (FTO) Considerations

  • The scope of AR045378 could be challenged based on existing patents or used defensively in patent clearance.

  • Competitive landscape may include patents on other formulations, delivery systems, or methods for similar therapeutic areas—like oncology, CNS disorders, or infectious diseases.

3. Patent Trends in Argentina

Patent filings in the pharmaceutical sector in Argentina tend to increase, reflecting growing innovation and market potential. However, patent examination remains rigorous, emphasizing novelty and inventive step, necessitating thorough prior art searches.


Strategic Implications

1. Patent Enforcement and Commercialization

The scope determines enforceability:

  • Broad claims provide significant protections but are more susceptible to invalidation.

  • Narrow claims, while safer legally, may limit the scope of exclusivity.

Monitoring for potential infringing activities involves investigating third-party filings and publications, adjusting patent enforcement strategies accordingly.

2. Licensing and Partnerships

AR045378 could be a valuable asset for licensing, particularly if it covers a novel therapeutic approach or formulation. Strategic alliances might enhance market penetration or R&D capabilities.

3. Challenges and Opportunities

  • Validity challenges from third parties focusing on prior art are common in pharmaceutical patents.

  • Patent lifecycle management, including timely filing of divisional or continuation applications, ensures broader or improved protection.


Regulatory and Market Context

Argentina's patent system aligns with regional standards, including compliance with TRIPS and local laws. The patent landscape interacts with regulatory pathways governed by ANMAT, which can influence the commercialization of patented drugs.

Pharmaceutical patent landscapes also reflect regional patent «evergreening» strategies—extending patent life through secondary claims or formulations, which would be crucial considerations for AR045378.


Conclusion

The Argentina patent AR045378 exhibits a strategically significant scope that likely covers a novel pharmaceutical composition, method, or use, with claims structured to balance breadth and robustness. The patent landscape indicates a competitive environment emphasizing innovation, with potential for licensing, enforcement, and strategic growth.

Thorough due diligence—covering prior art, patent family analysis, and market positioning—is essential for stakeholders aiming to leverage or navigate this patent effectively.


Key Takeaways

  • Scope clarity in AR045378’s claims dictates its enforceability and potential for opposition or challenge.

  • Strategic patent positioning involves balancing broad coverage with defensibility against prior art and invalidity claims.

  • Landscape monitoring is vital for assessing infringement risks, potential licensing opportunities, and competitive threats within Argentina and globally.

  • Patent lifecycle management ensures sustained protection; timely renewals and filing continuation applications are critical.

  • Integration with regulatory pathways enhances the drug development and commercialization process, maximizing patent value.


FAQs

1. What is the primary focus of patent AR045378?
While exact claims require detailed patent document review, patents with similar numbering typically cover pharmaceutical compounds, formulations, or therapeutic methods designed to treat specific conditions.

2. How does Argentina's patent law impact the scope of pharmaceutical patents like AR045378?
Argentina's Law No. 24,481 emphasizes novelty, inventive step, and industrial application, aligning with TRIPS standards. This legal framework influences the permissible scope and enforceability of claims, emphasizing clear, inventive, and non-obvious features.

3. Can AR045378 be challenged or invalidated after grant?
Yes. Third parties can file nullity or opposition procedures challenging validity based on prior art, lack of novelty, or inventive step, potentially narrowing or invalidating the patent.

4. How does this patent landscape influence drug development in Argentina?
Strong patent protection fosters innovation, incentivizing R&D investments. A clear landscape also guides companies in assessing freedom-to-operate and strategic patent filings.

5. Are there international equivalents or family members related to AR045378?
While the specific patent family data needs review, pharmaceutical patents are often part of international filings like PCT applications, facilitating broader protection outside Argentina.


References

[1] Argentine Patent Law No. 24,481.
[2] Argentine Patent Office (INPI) Official Records.
[3] WIPO patent database for international family analysis.
[4] Global Patent Landscape Reports, 2022.
[5] Industry reports on pharmaceutical innovation in Latin America.

More… ↓

⤷  Get Started Free

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.